REFERENCES
- Ashford M., Fell J. T., Attwood D., Sharma H., Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. J. Control. Rel. 1993; 26: 213–220, [CSA]
- Atyabi F., Sharma H. L., Mohammad H. A. H., Fell J. T. Controlled drug release from coated floating ion exchange resin beads. J. Control. Rel. 1996a; 42: 25–28, [CSA], [CROSSREF]
- Atyabi F., Sharma H. L., Mohammad H. A. H., Fell J. T. In vivo evaluation of a novel gastric retentive formulation based on ion echange resins. J. Control. Rel. 1996b; 42: 105–113, [CSA], [CROSSREF]
- Atyabi F., Inanlo K. Calcium pectinate as a carrier for albumin delivery. Proc. 30th Int. Symp. Control. Rel. Bioac. Mater. 2003
- Chourasia M. K., Jain S. K. Polysaccharides for colon targeted drug delivery. Drug Del. 2004; 11: 129–48, [CSA], [CROSSREF]
- Cummings J. H., Southgate D. A., Branch W. J., Wigging H. S., Houston H., Jenkins D. J., Jivraj T., Hill M. J. The digestion of pectin in the human gut and its effects on calcium absorption and large bowel function. Br. Nutr. 1979; 41: 477–485, [CSA], [CROSSREF]
- Gliko-Kabir I., Yagen B., Penhasi A., Rubinstein A. Phosphated crosslinked guar for colon-specific drug delivery, I. Preparation and physicochemical characterization. J. Control. Rel. 2000; 63: 121–127, [CSA], [CROSSREF]
- Gupta V. K., Beckert T. E., Price J. C. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int. J. Pharm. 2001; 213: 83–91, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kleinebudde T. T., Sande S. A. Extrusion/spheronization of pectin-based formulations. II. Effect of additive concentration in the granulation liquid. AAPS Pharm. Sci. Tech. 2001; 2: 27, [CSA]
- Krishnaiah Y. S. R., Indira Muzib Y., Srinivasa Rao G., Bhaskar P., Satyanarayana V. Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis. Drug Del. 2003; 10: 111–117, [CSA]
- Liu L., Fishman M. L., Kost J., Hicks K. B. Pectin-based systems for colon-specific drug delivery via oral route. Biomaterials 2003; 19: 3333–3343, [CSA], [CROSSREF]
- Pillay V., Danckwerts M. P., Fassihi R. A crosslinked calcium-alginate-pectinate-cellulose acetophthalate gelisphere system for linear drug release. Drug Del. 2002; 9: 77–86, [CSA], [CROSSREF]
- Pillay V., Fassihi R. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract: comparison of pH-responsive drug release and associated kinetics. J. Control. Rel. 1999; 59: 229–242, [CSA], [CROSSREF]
- Saffron M., Kumar G. S., Neekers D. S., Pena J., Jones R. H., Field J. B. Biodegradable azopolymer coating for oral delivery of peptide drugs. Biochem. Soc. Trans. 1990; 18: 752–754, [CSA]
- Semde R., Amighi K., Devleeschouwer M. J., Moes A. J. Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery. Int. J. Pharm. 2000; 197: 181–192, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sinha V. R., Kumria R. Microbially triggered drug delivery to the colon. Eur. J. Pharm. Sci. 2003; 18: 3–18, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Turkoglu M., Ugurlu T. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur. J. Pharm. Biopharm. 2002; 53: 65–73, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Uribe M., Moran S., Poo J. L., Mendez-Sanchez N., Guevara L., Garcia-Ramos G. Beneficial effect of carbohydrate maldigestion induced by a disaccharidase inhibitor (AO-128) in the treatment of chronic portal-systemic encephalopathy. A double-blind, randomized, controlled trial. Scand. J. Gastroenterol. 1998; 33: 1099–106, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Watts P. J., Illum L. Colonic drug delivery. Drug Dev. Ind. Pharm. 1997; 29: 893–913, [CSA]